On the show today we have Dr. Karin Hehenberger. Some of you might know Dr. Hehenberger from her amazing work with her venture LyfeBulb, but for those of you who are not familiar with her, Dr. Hehenberger is a type 1 who is no longer type 1.
Dr. Hehenberger has a list of credentials and professional accomplishments that make her the ultimate multi-hyphenate. She was on the Swedish National Tennis Team, she earned her Medical Doctorate and her PhD in molecular medicine, she was a post-doc fellow at Harvard, a consultant for McKinsey & Company, has worked in big pharma and start-up biotech companies, and the list goes on and on.
What’s remarkable about her story is that she navigated all of those challenging environments, and succeeded on a large scale, with type 1 diabetes. But as the years went on, and she experienced a period of significant burnout and poor control of her health, all the complications anyone with diabetes fears, started to set in. Dr. Hehenberger ultimately found herself with significant damage to her vision, and her kidneys were failing. She was on the edge of complete physical breakdown.
Ultimately, it was her father who saved her live with an incredible gift, and then a few months later it was a donor, and a very talented transplant team in Minnesota who would provide Dr. Hehenberger with a chance to experience life without type 1 again.
Dr. Hehenberger is the ultimate patient-entrepreneur and you’ll learn through this interview that she is all in when it comes to finding and supporting the next generation of budding patient-entrepreneurs through her venture catalyst LyfeBulb. As I release this episode, Dr. Hehenberger and her team are over in Copenhagen Denmark for this year’s LyfeBulb/ Novo Nordisk Innovation Summit where they will be working with some of the best young innovators in the world of diabetes.
There’s a lot to this story and our conversation is a deep look into denial, motivation, personal drive, an individual’s love of science, and a belief that those impacted by a chronic condition should be at the center of creating ventures that will help minimize the impact of that condition on the world.
Press Contact for Lyfebulb: Shepard Doniger BDCG, Inc. 561-637-5750 email@example.com
Dear Lyfebulb Community:
These are exciting times at Lyfebulb; with new opportunities and challenges we are growing our team and adding capabilities!
First, we are excited to announce Lisa Ricciardi as our newest board member. Ricciardi is a Life Sciences executive with deep business development and operational experience. She has worked for top pharmaceutical, payer, and molecular diagnostics firms, including Pfizer, Medco, and Foundation Medicine, as well as for Essex Woodlands Health Ventures, a global venture capital partnership. We are happy to welcome her into the Lyfebulb family.
Secondly, we would like to announce that Stephen Squinto, Lyfebulb co-founder, and venture partner at Orbimed, has assumed the position as chairman of Lyfebulb. Dr. Squinto has over 25 years of biotechnology industry experience and has received numerous honors and awards from academic and professional organizations for his scientific work. We are looking forward to working with Dr. Squinto to grow Lyfebulb this year.
Last, but not least, we have added Bruna Petrillo to our operational team as our Creative Director. Petrillo is a creative and passionate marketing strategist. She has worked in fashion marketing and fashion PR at start-up companies for the past three years. Prior to joining Lyfebulb, she was the marketing director for CARRIE HAMMER, where she assisted in revolutionizing the term ‘Role Models Not Runway Models.’
And, in case you missed it: Karin Hehenberger shared an important piece onHuffington Post asking: Why are venture capital firms less likely to invest in diabetes? Why is the average age of endocrinologists increasing, and why aren’t there more smaller public companies in the diabetes space? She argues that without the influx of talent, capital, and the right kind of media attention, we will never beat diabetes. Read more here.
The Lyfebulb Team
Dr. Hehenberger of Lyfebulb provides us with some key travel tips in this short video that are essential for diabetics and others with chronic disease. Some of her key tips include:
- Before traveling, do your research and find out where the nearest hospital or medical center is, relative to your hotel.
- Be sure to always pack your meds in your carry-on luggage.
- Inform your travel partner of your condition and also ask them to pack a spare supply of your meds just in case there are issues with your luggage.
- Make sure that you don’t let your insulin is stored in a suitable temperature and make sure not expose it to excess heat.
- Stay safe by taking necessary precautions and Enjoy Your Vacation!